Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intensifying Radiation Treatment in Advanced/ Poor Prognosis Laryngeal, Hypopharyngeal (LH) and Oropharyngeal Cancers (OPC) Using PET -CT Based Dose Escalation Strategies ( INTELHOPE)

NCT02757222 is registered in ClinicalTrials.gov with Tata Medical Center as lead sponsor.

NCT NCT02757222
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02757222 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intensifying Radiation Treatment in Advanced/ Poor Prognosis Laryngeal, Hypopharyngeal (LH) and Oropharyngeal Cancers (OPC) Using PET -CT Based Dose Escalation Strategies ( INTELHOPE)
Lead sponsor
Tata Medical Center
Phase
Not applicable
Overall status
Completed
Start date
January 31, 2016
Completion date
December 31, 2022
Enrollment
100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

malignant neoplasm of hypopharynx stage iii, malignant neoplasm of hypopharynx stage iva, malignant neoplasm of hypopharynx stage ivb, malignant neoplasm of larynx stage iii, malignant neoplasm of larynx stage iv, malignant neoplasm of oropharynx stage iii, malignant neoplasm of oropharynx stage iva, malignant neoplasm of oropharynx stage ivb